Your browser doesn't support javascript.
loading
Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines.
Takahashi, Kazuya; Inukai, Takeshi; Imamura, Toshihiko; Yano, Mio; Tomoyasu, Chihiro; Lucas, David M; Nemoto, Atsushi; Sato, Hiroki; Huang, Meixian; Abe, Masako; Kagami, Keiko; Shinohara, Tamao; Watanabe, Atsushi; Somazu, Shinpei; Oshiro, Hiroko; Akahane, Koshi; Goi, Kumiko; Kikuchi, Jiro; Furukawa, Yusuke; Goto, Hiroaki; Minegishi, Masayoshi; Iwamoto, Shotaro; Sugita, Kanji.
Afiliação
  • Takahashi K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Inukai T; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Imamura T; Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Yano M; Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Tomoyasu C; Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Lucas DM; College of Pharmacy, The Ohio State University, Columbus, OH, United States of America.
  • Nemoto A; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Sato H; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Huang M; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Abe M; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Kagami K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Shinohara T; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Watanabe A; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Somazu S; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Oshiro H; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Akahane K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Goi K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
  • Kikuchi J; Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical School, Shimotsuke, Japan.
  • Furukawa Y; Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical School, Shimotsuke, Japan.
  • Goto H; Hematology/Oncology & Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Minegishi M; Tohoku Block Center, Japanese Red Cross Society, Sendai, Japan.
  • Iwamoto S; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
  • Sugita K; Department of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
PLoS One ; 12(12): e0188680, 2017.
Article em En | MEDLINE | ID: mdl-29236701
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Linfócitos B / Bortezomib / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Linfócitos B / Bortezomib / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão